Clinical trial tests injectable vs oral HIV medications
A new clinical trial will determine if monthly injections of anti-viral drugs are more effective at suppressing the HIV virus than daily pills.
List view / Grid view
News
Collaboration to produce new clinical stage TB drug candidates
The National Institute of Allergy and Infectious Diseases (NIAID) has awarded TB Alliance a CETR grant for tuberculosis drug development.
Strong line-up for Chemspec Europe 2019
Chemspec Europe 2019 gathers impressive array of industry experts under one roof
New drug for Huntington lowers levels of disease-causing protein
A new drug for Huntington disease is found to be safe and lowers levels of the abnormal protein that causes the debilitating disease in patients.
Haseeb Ahmad has been named as the new president of ABPI
Haseeb Ahmad from Novartis Pharmaceuticals has been confirmed as the new president of the The Association of the British Pharmaceutical Industry (ABPI).
Sartorius Stedim Biotech introduces new SIMCA® 16 software for multivariate data analytics
Leading international partner to the biopharmaceutical industry Sartorius Stedim Biotech (SSB) has today announced that the new SIMCA® 16 software for multivariate data analytics is available from its subsidiary Sartorius Stedim Data Analytics.
FDA approves novel treatments for heart disease
The US Food and Drug Administration (FDA) has approved new treatments for heart disease caused by ATTR-CM in adults.
New digital filter aims to improve chemical measurements
A filter has been designed to create more exact measurements early in the drug development stage and help move a drug to clinical trials faster.
Report shows US brand-name drug prices ‘highest in the world’
A new study has found that prices for brand-name prescription drugs averaged 3.2 to 4.1 times higher in the US compared with other countries.
Novel colorectal cancer vaccine shows positive phase I results
A new vaccine for colorectal cancer has proven to be safe in a small sample of human subjects, opening the way for the next phase of testing.
Long-lasting opioid treatment recommended by an EMA committee
Marketing authorisation has been recommended in the EU by an EMA committee for Sixmo (buprenorphine) as a substitution treatment for opioid dependence.
Amgen and Astellas Pharma US agree to settlement costs for kickback charges
Amgen and Astellas Pharma US have agreed to pay a total of $124.75 million to settle allegations that they paid kickbacks to Medicare copays for their own medications.
$100 million is to be invested to increase vaccine manufacturing in US
A $100 million investment has been made to support long-term vaccine manufacturing capabilities in the US.
Application to EMA filed for the approval of oral semaglutide
It has been announced that a Marketing Authorisation Application (MAA) has been submitted to the European Medicines Agency (EMA) for oral semaglutide.
Legal ruling confirms that ‘routine’ discoveries can be patented
In a ruling handed down by the UK Supreme Court, Lord Hodge has confirmed that discoveries made through well-established or routine research protocols can be inventive and rewarded with a patent.
